The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 113: 813-823.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, S. M.
Right arrow Articles by Lucas, Z. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Walker, S. M.
Right arrow Articles by Lucas, Z. J.

Cytotoxic Activity of Lymphocytes

IV. Preparation of Heterologous Antibody to Human Lymphotoxin1

Sharyn M. Walker and Zoltan J. Lucas

From the Departments of Medical Microbiology and Surgery (Transplantation Biology), Stanford University School of Medicine, Palo Alto, California 94305

Abstract

Antibody to human lymphotoxin was elicited in rabbits immunized with partially purified supernatants of human spleen cells stimulated by phytohemagglutinin; Anti-LT activity, assayed by neutralizing soluble LT toxicity to indicator mouse L cells, is confined to the immunoglobulin fraction of the serum; it cannot be removed by adsorption to L cells, human fibroblasts or lymphocytes, or to human serum. Anti-LT activity is removed by immunoadsorption to Sepharose conjugated with goat antisera to rabbit 7S immunoglobulin; partial recovery of anti-LT activity is effected by elution with high molarity acid buffer. The amounts of antisera necessary to effect neutralization are linearly proportional to LT concentration. Anti-human LT neutralizes the toxicity of supernatants of human lymphocytes activated by other, non-PHA mitogens (antigens to which the lymphocyte donors are sensitive) and allogeneic lymphocytes in mixed leucocyte culture. However, anti-human LT is specific for human LT as it will not neutralize guinea pig or rat LT.

Footnotes

1 This work was supported in part by National Institutes of Health Grant AM 12458 and by the Beta Sigma Phi Kidney Research Fund.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.